These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8927977)

  • 41. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire.
    Casanova JL; Romero P; Widmann C; Kourilsky P; Maryanski JL
    J Exp Med; 1991 Dec; 174(6):1371-83. PubMed ID: 1836010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Piecing together the family portrait of TCR-CD3 complexes.
    Kuhns MS; Badgandi HB
    Immunol Rev; 2012 Nov; 250(1):120-43. PubMed ID: 23046126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination.
    Oldstone MB; Tishon A; Geckeler R; Lewicki H; Whitton JL
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2752-5. PubMed ID: 1372990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
    Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
    J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The T-Cell Receptor Can Bind to the Peptide-Bound Major Histocompatibility Complex and Uncomplexed β
    Merkle PS; Irving M; Hongjian S; Ferber M; Jørgensen TJD; Scholten K; Luescher I; Coukos G; Zoete V; Cuendet MA; Michielin O; Rand KD
    Biochemistry; 2017 Aug; 56(30):3945-3961. PubMed ID: 28671821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MHC-unrestricted killing by T cells--multireceptor hypothesis.
    Hersey P; Bolhuis RL
    Immunol Today; 1990 Apr; 11(4):110-1. PubMed ID: 2340064
    [No Abstract]   [Full Text] [Related]  

  • 48. Abnormal class I assembly and peptide presentation in the nonobese diabetic mouse.
    Li F; Guo J; Fu Y; Yan G; Faustman D
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11128-32. PubMed ID: 7972022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand.
    Orihuela M; Margulies DH; Yokoyama WM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11792-7. PubMed ID: 8876216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T cell receptor (TCR) recognition of MHC class I variants: intermolecular second-site reversion provides evidence for peptide/MHC conformational variation.
    Dyall R; Fremont DH; Jameson SC; Nikolić-Zugić J
    J Exp Med; 1996 Jul; 184(1):253-8. PubMed ID: 8691139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CTL-based cancer preventive/therapeutic vaccines for carcinomas: role of tumour-associated carbohydrate antigens.
    Franco A
    Scand J Immunol; 2005 May; 61(5):391-7. PubMed ID: 15882430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spontaneous partial loss of the OT-I transgene.
    Pritchard GH; Cross EW; Strobel M; Jameson SC; Kedl RM; Hogquist KA; Hunter CA
    Nat Immunol; 2016 May; 17(5):471. PubMed ID: 27092794
    [No Abstract]   [Full Text] [Related]  

  • 53. Imperfect interfaces.
    Ysern X; Li H; Mariuzza RA
    Nat Struct Biol; 1998 Jun; 5(6):412-4. PubMed ID: 9628472
    [No Abstract]   [Full Text] [Related]  

  • 54. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papilloma virus.
    Stauss HJ; Davies H; Sadovnikova E; Chain B; Horowitz N; Sinclair C
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):7871-5. PubMed ID: 1381502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elongated peptides, not the predicted nonapeptide stimulate a major histocompatibility complex class I-restricted cytotoxic T lymphocyte clone with specificity for a bacterial heat shock protein.
    Schoel B; Zügel U; Ruppert T; Kaufmann SH
    Eur J Immunol; 1994 Dec; 24(12):3161-9. PubMed ID: 7805744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding.
    Cole DK; Dunn SM; Sami M; Boulter JM; Jakobsen BK; Sewell AK
    Mol Immunol; 2008 May; 45(9):2700-9. PubMed ID: 18243322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MHC-unrestricted cytotoxicity.
    Faure F; Triebel F; Hercend T
    Immunol Today; 1990 Apr; 11(4):108-10. PubMed ID: 2378643
    [No Abstract]   [Full Text] [Related]  

  • 60. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
    De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.